EHA joins forces with the British Society of Haematology (BSH) & Annual Academy of Sickle Cell and Thalassaemia Conference (ASCAT) in organizing the 18th Annual Sickle Cell & Thalassaemia Conference.
Dates: October 25-28, 2023
Location: London, United Kingdom
Format: Physical only
The Annual Scientific Conference on Sickle Cell and Thalassaemia (ASCAT) focuses on promoting the latest advances in diagnosis, treatment, and emerging fields in hemoglobinopathies. It is an opportunity to interact with peers on the latest advances in clinical care, transition services, and emerging new therapies including updates for curative treatment options.
Abstract submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers as an oral presentation or poster.
Please select the most appropriate topic during the abstract & case submission:
Basic and translational
Novel therapies, gene therapies and bone marrow transplant
Artificial intelligence, deep learning and other technological advancements in hemoglobinopathies
Clinical, public health and epidemiological studies
Clinical, infection and nutritional deficiencies
Ageing and end organ damage
Health services and outcomes research including psychology
Abstract submission is closed
|April 17, 2023||Start abstract & case submission|
|August 18, 2023||Deadline abstract & case submission|
|September 1, 2023||Notification of allocation to authors|
For any questions regarding the abstract submission process, please contact firstname.lastname@example.org.
Consultant Hematologists, Pediatricians, Specialist Nurses, Psychologists, Scientists, Fellows and trainees in all related fields
The meeting will take place in County Hall, Westminster Bridge, London, United Kingdom.
For more information, click here.
The registration is open, for more info and to register click here.
The program has not been released yet, but once available it will be published here.
EHA Topics-in-Focus Hemoglobinopathies
This meeting is part of the EHA Topics-in-Focus (TIF) program on Hemoglobinopathies, aimed at raising awareness, providing education, furthering research, and building a network of experts to improve patient care. Further information, please see our website.